Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing zolmitriptan (medicinal product) |
Is a |
False |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Product containing naratriptan (medicinal product) |
Is a |
False |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Product containing rizatriptan (medicinal product) |
Is a |
False |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Almotriptan malate |
Is a |
True |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Naratriptan hydrochloride |
Is a |
True |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Rizatriptan benzoate |
Is a |
True |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Sumatriptan succinate |
Is a |
True |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Almotriptan (substance) |
Is a |
True |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Naratriptan (substance) |
Is a |
True |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Rizatriptan (substance) |
Is a |
True |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Zolmitriptan (substance) |
Is a |
True |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Frovatriptan succinate (substance) |
Is a |
True |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Product containing precisely sumatriptan (as sumatriptan succinate) 100 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Sumatriptan (as sumatriptan succinate) 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
sumatriptan 12 mg/mL, seringue préremplie de 0,5 mL d'une solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Product containing sumatriptan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Sumatriptan 20mg nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Product containing serotonin 5-hydroxytryptamine-1 receptor agonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
1 |
Sumatriptan 5mg nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Tegaserod maleate (substance) |
Is a |
False |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Almotriptan - chemical |
Is a |
False |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Product containing eletriptan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Eletriptan 20mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Eletriptan 40mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Sumatriptan (substance) |
Is a |
True |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Product containing precisely eletriptan (as eletriptan hydrobromide) 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Product containing precisely eletriptan (as eletriptan hydrobromide) 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Eletriptan (substance) |
Is a |
True |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Frovatriptan (substance) |
Is a |
True |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Eletriptan hydrobromide (substance) |
Is a |
True |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Frovatriptan succinate monohydrate (substance) |
Is a |
True |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Almotriptan hydrogen malate (substance) |
Is a |
True |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Vilazodone (substance) |
Is a |
True |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Vilazodone hydrochloride |
Is a |
True |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Eletriptan hydrobromide monohydrate |
Is a |
True |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Frovatriptan succinate anhydrous (substance) |
Is a |
True |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|
Sumatriptan hemisulfate |
Is a |
True |
Serotonin 5-HT1 receptor agonist |
Inferred relationship |
Some |
|